POMT2
Protein O-mannosyl-transferase 2
Also known as: LGMD2N, POMT2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UKY4
- Gene
- POMT2
- Ensembl
- ENSG00000009830
- Chromosome
- 14
- Canonical length
- 750 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is an O-mannosyltransferase that requires interaction with the product of the POMT1 gene for enzymatic function. The encoded protein is found in the membrane of the endoplasmic reticulum. Defects in this gene are a cause of Walker-Warburg syndrome (WWS).[provided by RefSeq, Oct 2008]
Canonical amino-acid sequenceUniProt
750 residues, UniProt reviewed canonical sequence.
>Q9UKY4|POMT2
1 MPPATGGGLA ESELRPRRGR CGPQAARAAG RDVAAEAVAR SPKRPAWGSR RFEAVGWWAL
61 LALVTLLSFA TRFHRLDEPP HICWDETHFG KMGSYYINRT FFFDVHPPLG KMLIGLAGYL
121 SGYDGTFLFQ KPGDKYEHHS YMGMRGFCAF LGSWLVPFAY LTVLDLSKSL SAALLTAALL
181 TFDTGCLTLS QYILLDPILM FFIMAAMLSM VKYNSCADRP FSAPWWFWLS LTGVSLAGAL
241 GVKFVGLFII LQVGLNTIAD LWYLFGDLSL SLVTVGKHLT ARVLCLIVLP LALYTATFAV
301 HFMVLSKSGP GDGFFSSAFQ ARLSGNNLHN ASIPEHLAYG SVITVKNLRM AIGYLHSHRH
361 LYPEGIGARQ QQVTTYLHKD YNNLWIIKKH NTNSDPLDPS FPVEFVRHGD IIRLEHKETS
421 RNLHSHYHEA PMTRKHYQVT GYGINGTGDS NDFWRIEVVN RKFGNRIKVL RSRIRFIHLV
481 TGCVLGSSGK VLPKWGWEQL EVTCTPYLKE TLNSIWNVED HINPKLPNIS LDVLQPSFPE
541 ILLESHMVMI RGNSGLKPKD NEFTSKPWHW PINYQGLRFS GVNDTDFRVY LLGNPVVWWL
601 NLLSIALYLL SGSIIAVAMQ RGARLPAEVA GLSQVLLRGG GQVLLGWTLH YFPFFLMGRV
661 LYFHHYFPAM LFSSMLTGIL WDTLLRLCAW GLASWPLARG IHVAGILSLL LGTAYSFYLF
721 HPLAYGMVGP LAQDPQSPMA GLRWLDSWDFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against POMT2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 10
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 11 nTPM
Expression across tissuesHPA
Tissue
- testis: 11 nTPM
- skeletal muscle: 11 nTPM
- pituitary gland: 6.5 nTPM
- thyroid gland: 5.9 nTPM
- adrenal gland: 5.4 nTPM
- endometrium: 4.8 nTPM
Single-cell type
- sertoli cells: 115 nCPM
- oligodendrocytes: 51 nCPM
- cone photoreceptor cells: 48 nCPM
- oligodendrocyte progenitor cells: 39 nCPM
- ependymal cells: 38 nCPM
- astrocytes: 38 nCPM
Immune cell
- memory B-cell: 0.1 nTPM
- non-classical monocyte: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- white matter: 25 nTPM
- medulla oblongata: 23 nTPM
- pons: 21 nTPM
- basal ganglia: 21 nTPM
- thalamus: 19 nTPM
- midbrain: 19 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about POMT2.
Disease | AllUniProt
Conditions POMT2 is implicated in, by any mechanism.
- Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A2 (MDDGA2) MIM:613150
- Muscular dystrophy-dystroglycanopathy congenital with impaired intellectual development B2 (MDDGB2) MIM:613156
- Muscular dystrophy-dystroglycanopathy limb-girdle C2 (MDDGC2) MIM:613158
Disease | GeneticClinVar
153 pathogenic / likely-pathogenic of 1,340 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2
- Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2
- Autosomal recessive limb-girdle muscular dystrophy type 2N
- Autosomal recessive limb-girdle muscular dystrophy
- POMT2-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.8
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.08
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- basement membrane organization
- dentate gyrus development
- protein O-linked glycosylation via mannose
- reactive gliosis
Molecular functions
- dolichyl-phosphate-mannose-protein mannosyltransferase activity
- mannosyltransferase activity
- metal ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of POMT2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads POMT2 as an antibody target. Whether an autoantibody or antibody against POMT2 could matter depends on whether native POMT2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
POMT2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label POMT2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...